Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease-Reference-Cited by-同舟云学术

Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease

Published:2004-08-16 Issue:4 Volume:114 Page:529-541
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Zheng Lemin,Nukuna Benedicta,Brennan Marie-Luise,Sun Mingjiang,Goormastic Marlene,Settle Megan,Schmitt Dave,Fu Xiaoming,Thomson Leonor,Fox Paul L.,Ischiropoulos Harry,Smith Jonathan D.,Kinter Michael,Hazen Stanley L.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference97 articles.

1. The oxidative modification hypothesis of atherogenesis: an overview

2. Atherosclerosis

3. Oxidized lipids as mediators of coronary heart disease

4. Myeloperoxidase-generated oxidants and atherosclerosis

5. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis

Cited by 651 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between high-density lipoprotein and functional outcome of ischemic stroke patients in a Taiwanese population;Lipids in Health and Disease;2024-08-29

2. Severe bronchiectasis is associated with increased carotid intima-media thickness;BMC Cardiovascular Disorders;2024-08-28

3. Enhancing Wound Healing and Anti-Inflammatory Effects by Combination of CIGB-258 and Apolipoprotein A-I against Carboxymethyllysine Toxicity in Zebrafish: Insights into Structural Stabilization and Antioxidant Properties;Antioxidants;2024-08-28

4. Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction;Antioxidants;2024-06-28

5. ApoA1/HDL-C ratio as a predictor for coronary artery disease in patients with type 2 diabetes: a matched case-control study;BMC Cardiovascular Disorders;2024-06-24